AIBT AIBOTICS, INC.

CIK 0001763329 9 ready 8-Ks latest October 2, 2026, 6:50 PM ET RSS · JSON

Activity: NORMAL 1 filings / 30d vs 0 baseline

Ready 8-Ks 9

Latest filing October 2, 2026, 6:50 PM ET

Top materiality 0.87

Event mix other_material ×5 · m_and_a ×3 · leadership ×1

Sentiment 3 pos · 2 neg · 4 neu

Recent 8-K filings for AIBT

Highest-materiality recent filing

Aibotics signs exchange agreement to acquire Empulser for up to $22M in Series C preferred stock

October 2, 2026, 6:50 PM ET M&A materiality 0.87 positive item 1.01 item 9.01

Aibotics entered an Oct. 2, 2026 exchange agreement to acquire 100% of Empulser Enterprises LLC; consideration is up to $22M in Series C Preferred Stock, 2,200,000 shares at $10.00.
Earn-out over 36 months: 220,000 shares at closing plus 198,000 shares per each of 10 milestones tied to patent filings, flight testing, pilot programs, and $500,000 cumulative revenue.

Read filing →

October 2, 2026, 6:50 PM ET M&A materiality 0.87 positive item 1.01 item 9.01

Aibotics signs exchange agreement to acquire Empulser for up to $22M in Series C preferred stock

Aibotics entered an Oct. 2, 2026 exchange agreement to acquire 100% of Empulser Enterprises LLC; consideration is up to $22M in Series C Preferred Stock, 2,200,000 shares at $10.00.
March 24, 2025, 7:59 PM ET other material materiality 0.35 neutral item 1.01 item 9.01

Aibotics enters $165K software dev agreement for Philbot massage robot app

Agreement with GMF Ventures LLC to develop iOS/Android apps for Philbot massage robot; total consideration $165,000.
August 21, 2024, 7:59 PM ET other material materiality 0.85 neutral item 1.01 item 5.03 item 9.01

Mycotopia exchanges 9.79M common shares for super voting preferred; Ehave gets 75% voting control

Ehave Inc. exchanged 9,793,754 common shares (≈67% of outstanding) for 1,000 Series A Super Voting Preferred shares.
March 28, 2024, 7:59 PM ET other material materiality 0.25 neutral item 4.01 item 9.01

Mycotopia Therapies auditor changes: Pinnacle resigns, Fruci appointed

Pinnacle Accountancy Group resigned as independent auditor on March 21, 2024.
December 5, 2023, 6:59 PM ET M&A materiality 0.70 positive item 1.01 item 2.01 item 3.02 item 7.01 item 9.01 ◈ M&A Transactions

Mycotopia Therapies acquires AI robotics assets from Philon Labs; up to $9M in stock, to rename AiBotics

Acquires patents for Phill Robot (AI massage robot) and Milky Way (smart breast-milk fridge) from Philon Labs.
May 3, 2023, 7:59 PM ET other material materiality 0.85 negative item 4.02 ◈ Auditor Changes

Mycotopia to restate 2022 financial statements; $288K cash comp and warrant to CEO omitted

Unrecorded $288,000 cash compensation and a warrant for 5% of fully diluted shares granted to CEO.
February 22, 2023, 6:59 PM ET other material materiality 0.60 negative item 1.02 item 7.01 item 9.01 ◈ Material Agreements

Mycotopia Therapies, PSLY.com, and Ei.Ventures mutually terminate merger agreement

Parties agreed to terminate the Agreement and Plan of Merger dated May 17, 2022 on February 16, 2023.
May 19, 2022, 7:59 PM ET M&A materiality 0.75 positive item 1.01 item 7.01 item 9.01

Mycotopia enters merger with Ei.Ventures under PSLY.com; total deal value ~$383M

Mycotopia shareholders to receive 0.25 PSLY.com share per TPIA share, valued at >$23M.
January 14, 2022, 6:59 PM ET leadership materiality 0.60 neutral item 1.01 item 9.01

Mycotopia Therapies appoints Benjamin Kaplan as CEO; $24k/mo consulting fee, 5% equity warrants

CEO appointment effective Jan 19, 2021; initial 36-month term with automatic 12-month renewal.

Materiality & sentiment trend

Max materiality 0.87 · Median 0.70 · Most common event other_material

3 positive 2 negative 4 neutral

source · AIBT on sec.gov